Literature DB >> 22551103

Warfarin in heart failure.

John W Eikelboom, Stuart J Connolly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22551103     DOI： 10.1056/NEJMe1202504

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.

Authors:  Siqin Ye; Bin Cheng; Gregory Y H Lip; Richard Buchsbaum; Ralph L Sacco; Bruce Levin; Marco R Di Tullio; Min Qian; Douglas L Mann; Patrick M Pullicino; Ronald S Freudenberger; John R Teerlink; J P Mohr; Susan Graham; Arthur J Labovitz; Conrado J Estol; Dirk J Lok; Piotr Ponikowski; Stefan D Anker; John L P Thompson; Shunichi Homma
Journal:  Am J Cardiol       Date:  2015-06-24       Impact factor: 2.778

2.  CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm.

Authors:  Siqin Ye; Min Qian; Bo Zhao; Richard Buchsbaum; Ralph L Sacco; Bruce Levin; Marco R Di Tullio; Douglas L Mann; Patrick M Pullicino; Ronald S Freudenberger; John R Teerlink; J P Mohr; Susan Graham; Arthur J Labovitz; Conrado J Estol; Dirk J Lok; Piotr Ponikowski; Stefan D Anker; Gregory Y H Lip; John L P Thompson; Shunichi Homma
Journal:  Eur J Heart Fail       Date:  2016-07-21       Impact factor: 15.534

3.  Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial.

Authors:  Patrick M Pullicino; John L P Thompson; Ralph L Sacco; Alexandra R Sanford; Min Qian; John R Teerlink; Haissam Haddad; Monika Diek; Ronald S Freudenberger; Arthur J Labovitz; Marco R Di Tullio; Dirk J Lok; Piotr Ponikowski; Stefan D Anker; Susan Graham; Douglas L Mann; J P Mohr; Shunichi Homma
Journal:  Cerebrovasc Dis       Date:  2013-07-30       Impact factor: 2.762

4.  Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.

Authors:  Patrick M Pullicino; Min Qian; Ralph L Sacco; Ron Freudenberger; Susan Graham; John R Teerlink; Douglas Mann; Marco R Di Tullio; Piotr Ponikowski; Dirk J Lok; Stefan D Anker; Gregory Y H Lip; Conrado J Estol; Bruce Levin; Jay P Mohr; John L P Thompson; Shunichi Homma
Journal:  Cerebrovasc Dis       Date:  2014-10-09       Impact factor: 2.762
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.